Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3301 Woodburn Rd
Ste 209
Annandale, VA 22003Phone+1 703-698-9254Fax+1 703-698-9256
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1980 - 1981
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1979 - 1980
- University of Sydney Faculty of MedicineClass of 1970
Certifications & Licensure
- CA State Medical License 1981 - Present
- VA State Medical License 2015 - 2026
- MD State Medical License 2020 - 2025
- DC State Medical License 2015 - 2024
- MN State Medical License 1985 - 2017
- WI State Medical License 1987 - 2003
Publications & Presentations
PubMed
- 106 citationsComparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trialPaul Angulo, E. Rolland Dickson, Terry M. Therneau, Roberta A. Jorgensen, Coleman Smith
Journal of Hepatology. 1999-05-01 - 4836 citationsPeginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.Michael W. Fried, Mitchell L. Shiffman, K. Rajender Reddy, C. Smith, George Marinos
The New England Journal of Medicine. 2002-09-26 - 216 citationsPeginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trialIra M. Jacobson, Robert S. Brown, B. Freilich, Nezam H. Afdhal, P. Kwo
Hepatology. 2007-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: